Anti-FRMD4A Intrabody [+36GFP] (IAB-B059(G))
Recombinant anti-FRMD4A intrabody in fusion with +36GFP works within cells to direct against human FRMD4A, expressed in CHO cells. The intrabody can be used in therapeutic methods for treating proliferative disorders, including squamous cell carcinoma (SCC).
Specifications
- Immunogen
- human FERM domain containing 4A
- Host
- human
- Type
- scFv-(+36GFP)
- Cell Penetrating Peptide
- +36 GFP
GFP with a theoretical net charge of +36 (+36 GFP) penetrated several different mammalian cell lines at very low (nanomolar) concentrations. Cationic peptides and proteins have been observed to penetrate cells, and both natural and synthetic cell-penetrating peptides are widely used as delivery vehicles. However, whereas a covalent link between the cell-penetrating peptide and its cargo is typically required.
- Species Reactivity
- human
- Applications
- Antibody assay: Enzyme-linked Immunosorbent Assay; Immunofluorescence; Neutralization; Functional studies
Target
- Alternative Names
- FRMD4A; FERM domain containing 4A; FRMD4; bA295P9.4; FERM domain-containing protein 4A; FERM domain containing 4
- Entrez Gene ID
- 55691
- UniProt ID
- Q9P2Q2
For lab research use only, not for diagnostic, therapeutic or any in vivo human use.
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email: